Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
life sciences
migraine
4
×
national blog main
amgen
eli lilly
fda
new york blog main
allergan
biohaven
calcitonin gene-related peptide
drugs
impel neuropharma
indiana blog main
indiana top stories
medical device
national
national top stories
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san francisco blog main
san francisco top stories
teva pharmaceutical
abbvie
acute migrane
alder biopharmaceutical
american academy of neurology
atogepant
bain capital
bausch health
bob azelby
boston blog main
boston top stories
botox
boulder/denver blog main
boulder/denver top stories
breast cancer
brian abrahams
What
migraine
4
×
class
drug
fda
new
approval
approved
companies
medicines
won
activity
adults
allergan
announced
arguments
big
biotech
commercialized
competitors
days
decades
decision
developed
dog
drugs
eli
firm
hasn’t
headache
ipo
ipos
late
leading
lilly
line
make
marks
meeting
monday
neuro
Language
unset
Current search:
migraine
×
migraine
×
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@xconomy.com
4 years ago
Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines